Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Coenzyme Q10 in Huntington's Disease (HD) (2CARE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University of Rochester
Information provided by (Responsible Party):
Merit E. Cudkowicz, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00608881
First received: February 4, 2008
Last updated: May 2, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)